Cover Story
Toxicology Biomarkers in Drug
Development
By Timothy P. Ryan , David E. Watson , Brian R.
Berridge
Now that the industry is immersed in microarray and
other genomic technologies, a new strategic direction is
needed to bring decision-based toxicology to its full
potential. This review focuses on short-term strategies
to increase return-on-investment when applying these
technologies to better identify candidate toxicology
biomarkers.
Features
The Future of Microarray
Readers
By Julian White
The author investigates the development of microarray
technology and, particularly, the use of microarray
readers in healthcare applications. The various elements
of current reader technology are reviewed and used to
predict the composition of readers for diagnostics and
screening.
Metrics and Management
Laboratory Informatics and
Financial Performance: A Meeting of Minds
By Gordon W. Logan
In this installment of our Metrics and management
column, Gordon Logan examines a subtle but significant
approach used by investors to ask not only what money is
being spent but also how it is being spent.
